121 related articles for article (PubMed ID: 16481416)
21. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.
Liu M; Chien CC; Burne-Taney M; Molls RR; Racusen LC; Colvin RB; Rabb H
J Am Soc Nephrol; 2006 Mar; 17(3):765-74. PubMed ID: 16481417
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
[TBL] [Abstract][Full Text] [Related]
23. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury.
Thurman JM; Royer PA; Ljubanovic D; Dursun B; Lenderink AM; Edelstein CL; Holers VM
J Am Soc Nephrol; 2006 Mar; 17(3):707-15. PubMed ID: 16467447
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis.
Wickham S; Lu B; Ash J; Carr DJ
J Neuroimmunol; 2005 May; 162(1-2):51-9. PubMed ID: 15833359
[TBL] [Abstract][Full Text] [Related]
25. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney.
Feng L; Cheng F; Ye Z; Li S; He Y; Yao X; Tang Q; Li Y
Transplant Proc; 2006 Sep; 38(7):2195-8. PubMed ID: 16980040
[TBL] [Abstract][Full Text] [Related]
26. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
Van den Steen PE; Deroost K; Van Aelst I; Geurts N; Martens E; Struyf S; Nie CQ; Hansen DS; Matthys P; Van Damme J; Opdenakker G
Eur J Immunol; 2008 Apr; 38(4):1082-95. PubMed ID: 18383042
[TBL] [Abstract][Full Text] [Related]
27. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
[TBL] [Abstract][Full Text] [Related]
29. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus.
Wenzel J; Proelss J; Wiechert A; Zahn S; Bieber T; Tüting T
J Am Acad Dermatol; 2007 Apr; 56(4):648-50. PubMed ID: 17367614
[TBL] [Abstract][Full Text] [Related]
30. Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.
Jiang PJ; Lin QD; Bao SM; Zhao AM; Zhang Y; Xiao SJ
Chin Med J (Engl); 2009 Feb; 122(4):390-5. PubMed ID: 19302742
[TBL] [Abstract][Full Text] [Related]
31. The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
Tsutahara K; Okumi M; Kakuta Y; Abe T; Yazawa K; Miyagawa S; Matsunami K; Otsuka H; Kaimori J; Takahara S; Nonomura N
Nephrol Dial Transplant; 2012 Oct; 27(10):3799-806. PubMed ID: 22904101
[TBL] [Abstract][Full Text] [Related]
32. Selective neutralization of the chemokine TCA3 reduces the increased injury of partial versus whole liver transplants induced by cold preservation.
Xie JF; Wang G; Debonera F; Han R; Dorf ME; Hancock W; Olthoff KM
Transplantation; 2006 Dec; 82(11):1501-9. PubMed ID: 17164723
[TBL] [Abstract][Full Text] [Related]
33. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
34. TLR4 activation mediates kidney ischemia/reperfusion injury.
Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
[TBL] [Abstract][Full Text] [Related]
35. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
Casas R; Lindau C; Zetterström O; Duchén K
Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
[TBL] [Abstract][Full Text] [Related]
38. Type I interferon-associated cytotoxic inflammation in lichen planus.
Wenzel J; Scheler M; Proelss J; Bieber T; Tüting T
J Cutan Pathol; 2006 Oct; 33(10):672-8. PubMed ID: 17026519
[TBL] [Abstract][Full Text] [Related]
39. Chemokines in ischemia and reperfusion.
Frangogiannis NG
Thromb Haemost; 2007 May; 97(5):738-47. PubMed ID: 17479184
[TBL] [Abstract][Full Text] [Related]
40. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
